Back to Authors

Howard, Matthew H.

Mayo Clinic

Mayo Clinic

Citations 2

Conventional Karyotyping and Fluorescence In Situ Hybridization
He, Rong , Wiktor, Anne E., Hanson, Curtis A. , Ketterling, Rhett P. , Kurtin, Paul J. , Dyke, Daniel L. Van , Litzow, Mark R. , Howard, Matthew H., Reichard, Kaaren K. , Ketterling, Rhett P

American Journal of Clinical Pathology | May 13, 2015 | Volume: 143 | Issue: 6 | Pages: 873-878

10.1309/ajcpp6lvmqg4lnck Get It

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A. , Kochuparambil, Samith T. , Abraham, Roshini S. , Rodriguez, Vilmarie , Howard, Matthew H., Jackson, Amie E., Holland, Steven M. , Patnaik, Mrinal M. , Hsu, Amy P.

Cancer Medicine | January 26, 2015 | Volume: 4 | Issue: 4 | Pages: 490-499

10.1002/cam4.384 Get It

AbstractGuanine‐adenine‐thymine‐adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.